Atin is a Director at Advent International and covers Technology Investments across US & India and Healthcare investments in India. He joined Advent in 2019 from Bain Capital, where he spent over five years working across Technology and Healthcare investments. Prior to that, he has worked at Bain & Company (Consulting) and Accenture (Technology). Atin has worked on numerous investments during his time at Advent and Bain Capital including Encora, Tredence, Brillio, QuEST Global, Bharat Serums & Vaccines, Cohance Lifesciences, Suven Pharma, Apollo 24×7 amongst others. He currently serves on the Boards of Encora, Tredence, and Sapala Organics.